|
 M.
James Barrett, Ph.D.
Chairman
Dr. Barrett is Chairman of the Board
of Directors for Sensors for Medicine and Science, Inc.®
(SMSI®). He is currently a General Partner
with the venture capital firm New
Enterprise Associates. In 1987, he founded Genetic
Therapy, Inc. (GTI) which was sold in August of 1995
to Swiss pharmaceutical giant Sandoz AG (now Novartis)
for $300 million. He continued to serve as GTI's CEO
and as a Director through June 1996. He founded SMSI
in 1997.
From 1982 to July of 1987, Dr. Barrett
served as President of Life Technologies, Inc. (now
part of Invitrogen)
and its predecessor, Bethesda Research Laboratories.
Prior to 1982, he was employed at SmithKline
Beecham Corporation for 13 years, where he held
a variety of positions, including President of its In
Vitro Diagnostics Division and President of SmithKline
Clinical Laboratories. Dr. Barrett has been a Director
of MedImmune,
Inc. since 1988. top
 Arthur
E. Colvin
Senior Scientist
Mr. Colvin has served as Senior
Scientist of SMSI since its inception in January 1997.
Mr. Colvin is the inventor of the Company's core technology,
and owner of the corresponding U.S. patent. Before founding
SMSI, Mr. Colvin founded and served as President of
Cerex, a private company that developed products for
the fermentation market and provided contract engineering
and manufacturing services. Prior to Cerex, Mr. Colvin
was a staff scientist and process development engineer
for Life Technologies, Inc., where he was involved in
new product development.
Mr. Colvin has developed or led
the development of more than 50 products for the biotechnology
and food industries. He has more than 30 issued and
pending patents. top
 Steven
J. Walters
Director of Operations
Mr. Walters has been Director of
Operations of SMSI since May 2001. He is responsible
for production and quality operations of the company,
including its commercially available oxygen sensor for
which his team has implemented a high volume production
process. Prior to joining SMSI, he was Director of Operations
for Dye Magnet Industries (DMI), a consumer product
company, where he helped commercialize a new product.
He also participated in the sale of the company to consumer
product giant Reckitt Benckiser. Before joining DMI,
Mr. Walters was President of Larox Inc., a Finnish owned
capital equipment manufacturer. He oversaw the growth
of this company for more than 15 years with expansions
in the USA, Canada and Mexico. top
 Paul
S. Strumph, M.D.
Chief Medical Officer
Dr. Strumph joined SMSI in February
2010. He is responsible for the Company’s clinical
and regulatory strategy.. Dr. Strumph brings expertise
in clinical development and in tailoring products most
effectively for people with diabetes and the medical
care community. Before joining SMSI, Dr. Strumph was
Vice President and Chief Medical Officer of the Juvenile
Diabetes Research Foundation. He also held leadership
positions in Clinical and Medical Affairs with Bristol-Myers
Squibb & Co., Merck KGaA and GlaxoSmithKline. Prior
to entering industry, Dr. Strumph was a practicing endocrinologist
and Clinical Assistant Professor at the UNC Department
of Medicine. top
Copyright © 2010 Sensors for Medicine and Science, Inc.®
All rights reserved. Date of last update: 07/28/10.
Refer to Terms and Conditions
for use of this Web site.
|
